Recent Quarter Total Invested
$12.35 M
Recent Quarter Institutional Ownership Percentage
46.69%
Total Invested of Last Quarter
$11.88 M
Ownership Percentage of Last Quarter
39.9%
Xilio Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 08/12/2024 | 3.79 M | $3.59 M | 34.93% | 13.56% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 3.00 M | $2.85 M | 108.45% | 10.76% |
| RIVERVEST VENTURE MANAGEMENT LLC | 07/24/2024 | 1.44 M | $1.37 M | 0.00% | 5.16% |
| FMR LLC | 08/13/2024 | 1.40 M | $1.32 M | -26.83% | 5.00% |
| MORGAN STANLEY | 08/14/2024 | 1.11 M | $1.05 M | 401.45% | 3.99% |
| VANGUARD GROUP INC | 08/13/2024 | 902,531 | $855,148 | 0.00% | 3.23% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 295,000 | $279,513 | 18.26% | 1.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 272,486 | $258,180 | -19.51% | 0.98% |
| FIL LTD | 08/13/2024 | 218,705 | $207,223 | 0.00% | 0.78% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 182,855 | $173,289 | 115.56% | 0.66% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 71,081 | $67,349 | 0.00% | 0.25% |
| BLACKROCK INC. | 08/13/2024 | 66,418 | $62,931 | 46.44% | 0.24% |
| STATE STREET CORP | 08/14/2024 | 43,390 | $41,112 | 176.55% | 0.16% |
| SEVENBRIDGE FINANCIAL GROUP, LLC | 08/09/2024 | 41,000 | $37,179 | 32.26% | 0.15% |
| NORTHERN TRUST CORP | 08/14/2024 | 39,208 | $37,150 | 120.29% | 0.14% |
| RAYMOND JAMES & ASSOCIATES | 07/19/2024 | 38,825 | $36,787 | 100.00% | 0.14% |
| XTX TOPCO LTD | 08/12/2024 | 33,289 | $31,541 | 100.00% | 0.12% |
| AVANTAX PLANNING PARTNERS, INC. | 08/09/2024 | 25,000 | $23,688 | 100.00% | 0.09% |
| TWO SIGMA SECURITIES, LLC | 08/14/2024 | 13,271 | $12,574 | 100.00% | 0.05% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 12,205 | $11,564 | -82.61% | 0.04% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 11,925 | $11,299 | 0.00% | 0.04% |
| DUNHILL FINANCIAL, LLC | 08/09/2024 | 10,274 | $9,735 | 0.00% | 0.04% |
| PINNACLE FINANCIAL GROUP, LLC / IL | 08/08/2024 | 10,000 | $9,475 | 100.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 4,207 | $3,988 | -62.28% | 0.02% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 1,500 | $1,421 | 100.00% | 0.01% |
| KEY FINANCIAL INC | 07/30/2024 | 830 | $786 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 692 | $656 | 100.00% | 0.00% |
| UBS GROUP AG | 08/14/2024 | 201 | $191 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2024 | 59 | $56 | -97.85% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 4 | $4 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SUMMIT TRAIL ADVISORS, LLC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| FNY INVESTMENT ADVISERS, LLC | 08/05/2024 | 0 | $0 | -100.00% | 0.00% |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 08/09/2024 | 0 | $0 | -100.00% | 0.00% |
| PFG INVESTMENTS, LLC | 08/07/2024 | 0 | $0 | -100.00% | 0.00% |
Xilio Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of XLO shares?
During the previous two years, 40 institutional investors and hedge funds held shares of Xilio Therapeutics, Inc.. The most heavily invested institutionals were:
Bain Capital Life Sciences Investors, LLC: 3.79 M
Rock Springs Capital Management LP: 3 M
RiverVest Venture Management LLC: 1.44 M
FMR LLC: 1.4 M
MORGAN STANLEY: 1.11 M
VANGUARD GROUP INC: 902,531
-
What percentage of Xilio Therapeutics, Inc. stock is owned by institutional investors?
46.69% of Xilio Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at XLO ?
Institutional investors have bought a total of 13.95 M shares in the last 24 months. This purchase volume represents approximately $10.74 M in transactions.